% YoY, -1% QoQ. In this quarter, the decline in prepaid base (-313k) decelerated comparing to -532k in 2Q20 which reflected loss in traveler segment from pandemic. Prepaid ARPU recovered slightly, rising
down in April during fully lockdown, however the market recovered in June with the growth of 18.0%, partly driven by additional supply of C-Vitt from capacity expansion. COVID-19 situation accelerated
, the government had carefully eased its measures to restore the business sector. Consequently, the business activities began to recover as well as the patients’ traffic was also gradually recovered
recovered. Bank of Thailand has adjusted down Thailand economic outlook forecast to a contraction of 8.1% for 2020, instead of 5.3% contraction previously forecasted. The crisis of the COVID-19 pandemic has
Administration (CFDA) at the beginning of 2 0 1 8 as the Company had to redesign its packaging to comply with the requirements of the license. Furthermore, the Company also found it necessary to adjust its sales
year to be in parallel with the plunge in sales revenue. Nevertheless, some of the sales expenses did not adjust promptly and did not fully mirror the slowdown in revenue as there is a lead time for
ongoing outbreak of COVID–19, forcing many customers to adjust their working method which have an effect on the operation and delivery of the Company's projects that cause the operation to be delayed than
reducing production cost and also negotiating with customers to review and adjust selling price every quarter. 2.2. Distribution costs for 2018 was in the amount of 4.95 million baht, increased by 1.16
with the plunge in sales revenue. Nevertheless, some of the sales expenses did not adjust promptly and did not fully mirror the slowdown in revenue as there is a lead time for certain expenses that the
granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change